Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Opentrons develops laboratory automation systems and robotics for life science research and biotechnology applications.
IVerify is a mobile threat hunting company that provides mobile security solutions.
Aventra Defense Systems operates as a defense technology start-up.
HealthSnap is a virtual care management platform for chronic disease management.
LimaCharlie is an Information security tools & infrastructure delivered in a manner similar to AWS.
Allotera Therapeutics is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies
Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.
RevEng.ai is a deep AI framework for analysing binary computer programs.
Lyra helps companies improve access to effective mental health care for their employees.
Cnuic Technologies has developed a working prototype of a completely new type of photolithography device.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Keebler Health develops an AI-powered healthcare analytics platform focused on risk adjustment and clinical decision support.
Red Sift's Digital Resilience Platform protects your perimeter, your brand and your supply chain.
Powering precision proteomics to enable to the earliest detection of disease.
Codoxo leverages advanced generative and self-learning AI to enhance payment integrity in healthcare.
PolyAI develops conversational artificial intelligence software that enables organizations to automate customer service interactions.
Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.
Klaviyo is an automation and email platform designed to help grow businesses.
Chronicle Studios operates as an entertainment company.
Spyglass Pharma provides medicine for ophthalmic diseases.
Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.
Specialty-specific healthcare SaaS solutions including AI-Powered EHRs, Practice Management, Analytics, RCM, Patient Engagement, Payments
CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.
AI based, real-time Anti Money Laundering (AML) detection, Fraud Prevention, Sanction Screening.
Sands Capital Ventures has invested in 100 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sands Capital Ventures's top investment sectors include Artificial Intelligence (AI), Health Care, Biotechnology, Information Technology, Life Science. The firm invests across 56 different industry categories.
Among tracked funding rounds, Taysha Gene Therapies received $200.0M in a Post-IPO Equity round. Sands Capital Ventures's total known invested capital is $4.7B.
Sands Capital Ventures's average investment size is $46.7M across its portfolio of 100 companies.
Recent Sands Capital Ventures portfolio additions include Opentrons, iVerify, Aventra Defense Systems, HealthSnap, LimaCharlie. These companies were founded in 2020 or later.